| # | Drug | Count |
|---|---|---|
| 0 | BISOPROLOL FUMARATE | 13 |
| 1 | PANITUMUMAB | 8 |
| 2 | ACARBOSE | 6 |
| 3 | INSULIN GLARGINE | 6 |
| 4 | PAZOPANIB HYDROCHLORIDE | 6 |
| 5 | SITAGLIPTIN | 6 |
| 6 | ABEMACICLIB | 5 |
| 7 | FLUOROURACIL | 5 |
| 8 | FLUOROURACIL CREAM, 0.5% | 5 |
| 9 | LOPERAMIDE HYDROCHLORIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACARBOSE | 6 | 0.0015 |
| 1 | NIROGACESTAT | 1 | 0.0011 |
| 2 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0007 |
| 3 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 4 | PANITUMUMAB | 8 | 0.0005 |
| 5 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 6 | SOTORASIB | 1 | 0.0003 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 8 | ABEMACICLIB | 5 | 0.0002 |
| 9 | PAZOPANIB HYDROCHLORIDE | 6 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 6 | 0.0012 |
| 1 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 8 | 0.0002 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 4 | Aromatase Inhibitor [EPC] | 5 | 0.0000 |
| 5 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 10 | 0.0000 |